IL6 and neoplasm: Cancer-derived EVs may also activate the tumor-associated macrophages and consequently activate the secretion of vascular endothelial growth factor (VEGF), IL-6, miRNAs, and transcription factors, which together promote angiogenesis, contributing to tumor progression.